AKT1 and B-cell chronic lymphocytic leukemia: BTKis, targeting such CLL-intrinsic pathway activation that is elicited by milieu stimuli, disrupt downstream cascades like PI3K–protein kinase B (PI3K–AKT) and NFκB networks, potentially weakening the TME’s support for CLL cells.